The attorneys general want to block the sale of personal genetic data without customer consent.
23 and Me filed for bankruptcy in March and found a buyer last month, Regeneron Pharmaceuticals.
RELATED: 23andMe bankruptcy: How to delete your data, destroy your genetic samples
That biotech company said it would comply with privacy policies set by the testing company.
A court-appointed independent review of the sale will determine how it might affect consumer privacy.